Tony Casciano

Tony Casciano joined Viridian as Chief Commercial Officer in 2023.  Most recently, Tony served as CEO of an MIT medical device spinout, where he successfully led and closed a Series A financing. Prior to that, Tony served as the COO & CCO of AMAG Pharmaceuticals, where he oversaw all commercial activities, as well as technical operations, global supply chain, corporate planning, and information technology. During his 4 years at AMAG Tony led the turnaround of the hematology oncology franchise and several successful product launches in highly competitive specialty and orphan disease markets, including infused products and subcutaneous autoinjectors. Prior to AMAG, he spent 16 years leading various commercial functions with increasing levels of responsibility at Sanofi and Genzyme.

Tony holds a B.A. in exercise science from Bridgewater State University, and executive certificates in marketing from the Wharton School of the University of Pennsylvania and in Governance from the Kellogg School of Management at Northwestern University.